Literature DB >> 7759093

Genetic dissection of susceptibility to radiation-induced apoptosis of thymocytes and mapping of Rapop1, a novel susceptibility gene.

N Mori1, M Okumoto, M A van der Valk, S Imai, S Haga, K Esaki, A A Hart, P Demant.   

Abstract

Genetic dissection of susceptibility to radiation-induced apoptosis of thymocytes was performed by counting dead cells in histologically processed thymuses after 0.5 Gy of whole-body X-irradiation, using recombinant congenic (CcS/Dem) strains derived from inbred mouse strains BALB/cHeA (susceptible) and STS/A (resistant). A high (8/20) number of strains with lower dead cell scores than BALB/cHeA among CcS/Dem recombinant congenic strains (RCS), which contain 12.5% of STS/A genome in the genetic background of BALB/cHeA strain, indicates that the difference between BALB/cHeA and STS/A is caused by several genes and that susceptibility probably requires BALB/cHeA alleles at more than one locus. Similar results were obtained with CXS/Hg recombinant inbred (CXS/Hg) strains. Analysis of F2 hybrids between BALB/cHeA and CcS-7, one of the CcS/Dem strains that showed lower dead cell scores than BALB/cHeA, demonstrated that a novel gene (Rapop1, radiation-induced apoptosis 1) controlling susceptibility to radiation-induced apoptosis in the thymus is located in the proximal region of mouse chromosome 16.

Entities:  

Mesh:

Year:  1995        PMID: 7759093     DOI: 10.1016/0888-7543(95)80001-3

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  9 in total

1.  Genetic composition of the recombinant congenic strains.

Authors:  A P Stassen; P C Groot; J T Eppig; P Demant
Journal:  Mamm Genome       Date:  1996-01       Impact factor: 2.957

2.  Simulation of the distribution of parental strains' genomes in RC strains of mice.

Authors:  C J Moen; H J Stoffers; A A Hart; H V Westerhoff; P Demant
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

3.  Identical genetic control of MLC reactivity to different MHC incompatibilities, independent of production of and response to IL-2.

Authors:  V Holán; M Lipoldová; P Demant
Journal:  Immunogenetics       Date:  1996       Impact factor: 2.846

4.  Mapping of new recessive cataract gene (lr2) in the mouse.

Authors:  C W Song; M Okumoto; N Mori; J S Kim; S S Han; K Esaki
Journal:  Mamm Genome       Date:  1997-12       Impact factor: 2.957

5.  Genetics of susceptibility to radiation-induced apoptosis in colon: two loci on chromosomes 9 and 16.

Authors:  N Mori; T van Wezel; M van der Valk; J Yamate; S Sakuma; M Okumoto; P Demant
Journal:  Mamm Genome       Date:  1998-05       Impact factor: 2.957

6.  Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models.

Authors:  Anneke C Blackburn; D Joseph Jerry
Journal:  J Mammary Gland Biol Neoplasia       Date:  2011-03-08       Impact factor: 2.673

7.  Separation of multiple genes controlling the T-cell proliferative response to IL-2 and anti-CD3 using recombinant congenic strains.

Authors:  M Lipoldová; M Kosarová; A Zajícová; V Holán; A A Hart; M Krulová; P Demant
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

Review 8.  Influence of Microgravity on Apoptosis in Cells, Tissues, and Other Systems In Vivo and In Vitro.

Authors:  Binod Prasad; Daniela Grimm; Sebastian M Strauch; Gilmar Sidnei Erzinger; Thomas J Corydon; Michael Lebert; Nils E Magnusson; Manfred Infanger; Peter Richter; Marcus Krüger
Journal:  Int J Mol Sci       Date:  2020-12-09       Impact factor: 5.923

9.  Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome.

Authors:  Prabin Dhangada Majhi; Nicholas B Griner; Jacob A Mayfield; Shannon Compton; Jeffrey J Kane; Trevor A Baptiste; Karen A Dunphy; Amy L Roberts; Sallie S Schneider; Evan M Savage; Divyen Patel; Anneke C Blackburn; Kim Joana Maurus; Lisa Wiesmüller; D Joseph Jerry
Journal:  Oncogene       Date:  2021-06-28       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.